Carteolol Related Published Studies
Well-designed clinical trials related to Carteolol (Carteolol Ophthalmic)
[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. [2010.11]
[Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product] [2007.06]
Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. [2006.08]
Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma. [2006.01]
Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients. [2005.12]
Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study. [2004.11]
[Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study] [2003.02]
Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma. [2003.01]
Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity. [2002.09]
Ocular hypotensive efficacy and safety of once daily carteolol alginate. [2001.08]
Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects. [2000.02]
Central nervous system and plasma lipid profiles associated with carteolol and timolol in postmenopausal black women. [1999.12]
Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma. [1999.02]
Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. [1998.01]
Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group. [1997.10]
Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group. [1997.10]
Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group. [1997.04]
The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients. [1996.08]
Fixed combination of carteolol and pilocarpine eye-drops: a double-blind randomized cross-over trial versus carteolol alone on intra-ocular pressure. The Study Group. [1996.01]
[Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension] [1995]
[Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension] [1995]
Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol. [1994.03]
A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol. [1994]
Acute effect of topical carteolol on ocular pulsatile volume change. [1993.12]
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. [1993.11.15]
[The effect of carteolol. Prolonged and increased effect by liposome suspension] [1992.12]
Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective study. [1992.10]
[Effect of 8-hydroxycarteolol in normal human eyes] [1992.07]
Effect of topical carteolol on the normal human retinal circulation. [1992.05]
Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol. [1992.04]
Carteolol incorporated into FAT-MLV liposomes: prolonged and decreased reduction of IOP. [1992]
An examination of the hemodynamic and metabolic effects of carteolol during different workloads on a bicycle ergometer. [1991.12]
A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma. [1991]
Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. [1990]
Surface anesthetic effect and subjective compatibility of 2% carteolol and 0.6% metipranolol in eye-healthy people. [1990]
Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension. [1989.12]
[Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes] [1989.04]
[Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head.] [1989]
The 12-hour control of intraocular pressure on carteolol 2% twice daily. [1988.12]
Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity. [1988.08]
A comparison of carteolol and nadolol in the treatment of stable angina pectoris. [1988.07]
A double-masked comparison of carteolol and timolol in ocular hypertension. [1988.02.15]
A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure. [1988.01]
A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure. [1987.10]
Well-designed clinical trials possibly related to Carteolol (Carteolol Ophthalmic)
[The ocular hypotensive effect and safety of 0.2% brimonidine] [2001.12]
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma. [2001.08]
The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study. [2001.01]
Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer. [1997.11]
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. [1996.11]
[Effect of topical adrenergic agents on tissue circulation in human optic nerve head evaluated with a laser speckle microcirculation analyser] [1996.01]
Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers. [1995]
Effects of beta-adrenoceptors blocking eye drops in patients with chronic bronchitis. [1992.05]
Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension. [1991.04]
Dynamic association between artery shear flow condition and platelet cytosolic free Ca2+ concentration in human hypertension. [1990.12]
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition. [1990.05]
[Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension] [1990.03]
[Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops] [1989]
Effect of different antiglaucomatous drugs on ocular perfusion pressures. [1988.09]
Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentration-heart rate response relationship. [1987.12]
Other research related to Carteolol (Carteolol Ophthalmic)
[Effects of carteolol hydrochloride on experimental choroidal neovascularization]. [2011.04]
Time course of changes in ocular aberrations after instillation of carteolol long-acting solution and timolol gel-forming solution. [2011.04]
Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. [2010.03.15]
Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma. [2010.03]
[The influence of carteolol and pentoxyphylin on the visual field in glaucoma patients--case reports of selected patients] [2010.02]
[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV
study--investigation of the effectiveness, safety and plasma concentration]. [Article in Japanese] [2010]
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. [2007]
Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. [2006.01]
Cytoprotective effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice. [2003.07]
Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit. [2002.02]
Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol. [2001.12]
Color Doppler imaging of retrobulbar hemodynamics after topical carteolol in normal tension glaucoma. [2001.10]
Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%. [2001.07]
A new long acting ophthalmic formulation of carteolol containing alginic acid. [2000.10.10]
Effect of Carteolol Hydrochloride on Ocular Blood Flow Dynamics in Normal Human Eyes. [2000.09.01]
[Effect of carteolol hydrochloride on ocular blood flow dynamics in normal human eyes] [2000.04]
Effect of continuous intravenous infusion of carteolol chloride on tissue blood flow in rabbit optic nerve head. [1999.11]
Pharmacokinetic and pharmacodynamic interactions among haloperidol, carteolol hydrochloride and biperiden hydrochloride. [1999.07]
Effects of topical carteolol and timolol on tissue circulation in the iris and choroid. [1999.05]
[The effect of continuous and intravenous application of carteolol chloride on tissue blood flow in the rabbit optic nerve head] [1998.10]
Effect of topical carteolol on iridial circulation in pigmented rabbit eyes. [1998.05]
Effect of topical carteolol on tissue circulation in the optic nerve head. [1998.01]
Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system. [1997.11]
Intracerebral penetration of carteolol hydrochloride in rats. [1997.06]
[Effect of topical carteolol on visual function in normal-tension glaucoma] [1997.03]
[Effect of topical carteolol on tissue circulation in rabbit optic nerve head evaluated with the laser speckle microcirculation analyser] [1995.08]
Ocular distribution of carteolol after single and repeated ocular instillation in pigmented rabbits. [1994.12]
Anti-obesity and anti-diabetic effects of carteolol in non-insulin-dependent diabetic mice. [1994.06]
Circadian blood pressure change after carteolol chloride in younger and older hypertensive patients. [1993.03]
Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery. [1993.03]
Effects of nanomolar to submillimolar carteolol on noradrenaline release in the absence and presence of uptake1 and uptake2 blockers in guinea pig pulmonary arteries. [1992.12]
Combination of nifedipine and carteolol compared to nifedipine alone in diurnal blood pressure variation and exercise blood pressure in patients with essential hypertension. [1992.01]
Protective effect of carteolol, a beta-blocker, on myocardial cellular damage in ischemic and reperfused pig hearts: assessment with gated in vivo 31-phosphorus magnetic resonance spectroscopy and electron microscopy. [1992.01]
Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. [1992.01]
A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants. [1992]
Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol. [1991.11]
[Effect of topical 8-hydroxy carteolol on intraocular pressure and melanin granules] [1991.08]
Effects of chronic administration of carteolol on beta-adrenoceptors in spontaneously hypertensive rat heart. [1991.08]
Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. [1991.06]
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. [1990.05]
Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension. [1990.03]
Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol. [1989.02]
|
